Company Monitoring Page for AbbVie

latest headlines for company on cafepharma

Q1 Earnings Preview: AbbVie, AstraZeneca, BMS, Celgene, Roche, Sanofi
BioPharma Dive
Wed, 04/26/17 - 09:29 pm
Tags:
earnings, AbbVie, AstraZeneca, Bristol-Myers Squibb, Celgene, Roche, Sanofi
Failure Of Abbvie's Cancer Drug Hasn't Hurt The Stock
Barron's
Fri, 04/21/17 - 11:28 am
Tags:
AbbVie, veliparib
AbbVie, Enanta post stellar hep C PhIII data, but no one is cheering
Endpoints
Thu, 04/20/17 - 08:52 pm
Tags:
AbbVie, Enanta, hepatitis C, glecaprevir/pibrentasvir
Report: Price hikes are still driving pharma's earnings growth. Who's most at risk?
Fierce Pharma
Wed, 04/19/17 - 04:21 pm
Tags:
earnings, drug pricing, Bristol-Myers Squibb, AbbVie, Roche
Lilly and Incyte's Loss Is AbbVie and Regeneron's Gain
Motley Fool
Mon, 04/17/17 - 12:07 pm
Tags:
Eli Lilly, Inctye, AbbVie, Regeneron, rheumatoid arthritis, FDA, baricitinib, Humira
Lilly, Pfizer, et al. back Sanofi and Regeneron in PCSK9 patent appeal. AbbVie doesn't
Fierce Pharma
Tue, 04/4/17 - 12:13 am
Tags:
Eli Lilly, Pfizer, Sanofi, AbbVie, Regeneron, patents, PCSK9 inhibitors, Repatha
Pharma's most-valuable brands? J&J, Pfizer and Merck. Valeant, not so much
Fierce Pharma
Sat, 04/1/17 - 08:14 am
Tags:
JNJ, Pfizer, Merck, AbbVie, Eli Lilly, Bristol-Myers Squibb
How AbbVie Is Attacking Tumors at Their Roots
Motley Fool
Wed, 03/29/17 - 09:06 am
Tags:
AbbVie, solid tumors, cancer, stem cells, Stemcentrx, Rova-T
3 Things You Probably Didn't Know About AbbVie Inc.
Motley Fool
Tue, 03/28/17 - 10:16 am
Tags:
AbbVie, dividends, debt
AbbVie's Hepatitis C Treatment Under Priority Review in Japan
Yahoo/GuruFocus
Wed, 03/15/17 - 09:47 pm
Tags:
AbbVie, hepatitis C, Japan, glecaprevir/pibrentasvir
AbbVie chief's $20M-plus pay—and company jet-setting—headed skyward in 2016
Fierce Pharma
Fri, 03/10/17 - 09:53 am
Tags:
AbbVie, Pharma CEOs, executive pay, Richard Gonzalez
2016 went out like a lamb in the biopharma M&A world. Will it roar back in 2017? Plus, top 10 deals
Endpoints
Wed, 02/22/17 - 11:43 am
Tags:
M&A, Shire, Baxalta, Pfizer, Medivation, Mylan, Meda, AbbVie, Stemcentrx, Anacor
AbbVie Announces $5 Billion Increase to Stock Repurchase Program
Yahoo
Sat, 02/18/17 - 02:22 pm
Tags:
AbbVie, stock buyback
Pfizer says rheumatoid arthritis drug is comparable to Humira as combination treatment but not alone
Marketwatch
Thu, 02/16/17 - 03:13 pm
Tags:
Pfizer, Xeljanz, AbbVie, Humira, rheumatoid arthritis
U.S. FDA Grants Priority Review to AbbVie for its Investigational Regimen of Glecaprevir/Pibrentasvir (G/P) for the Treatment of Chronic Hepatitis C in All Major Genotypes (GT1-6)
Yahoo
Thu, 02/2/17 - 09:22 am
Tags:
FDA, AbbVie, glecaprevir/pibrentasvir, G/P, hepatitis C
AbbVie Slides on Mixed Q4 Earnings
Yahoo/24-7 Wall St
Fri, 01/27/17 - 09:34 am
Tags:
AbbVie, earnings
AbbVie’s Anti-Tau Antibody Enters Phase II Clinical Trials for Alzheimer’s Disease
Xtalks
Fri, 01/27/17 - 09:30 am
Tags:
AbbVie, clinical trials, anti-tau antibodies, Alzheimer's disease, ABBV-8E12
AbbVie Gets FDA Approval for Lymphoma Drug
Yahoo/GuruFocus
Mon, 01/23/17 - 10:24 am
Tags:
AbbVie, FDA, Imbruvica, marginal zone lymphoma, MZL
Earnings preview: 7 biopharmas to watch
BioPharma Dive
Sat, 01/21/17 - 11:49 am
Tags:
earnings, JNJ, Novartis, Vertex Pharmaceuticals, Biogen, Celgene, Bristol-Myers Squibb, AbbVie
Boehringer Ingelheim's Humira Biosimilar Under Review by EMA, FDA
Yahoo/GuruFocus
Fri, 01/20/17 - 09:45 am
Tags:
Boehringer Ingelheim, Humira, biosimilars, FDA, EMA, BI 695501, AbbVie

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.